due to math and achievement of certain events VXGN shareholders may achieve 1.10 based on OXGN pps of 1.6


15.6 mill OXGN new shares issued at 1.42=22.15 mill=.67$ per share offerde to VXGN commons

additional 8.5 millions OXGN new shares to be issued to ex VXGN common (in the event of lease liability settlement plus potential milestone payment for antrax vaccine from emerging bio sol) or .37$ per ex VXGN common shares, when and if certain events succeed and OXGN pps remain at 1.42